Author

A. Kaminitz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:mechanistic / dynamical model· 1

Frequent Co-Authors

A. Madi· 1 shared A. von Deimling· 1 shared C. Kraemer· 1 shared C. L. TaniD· 1 shared F. Cichon· 1 shared K. Jaehne· 1 shared K. Lindner· 1 shared K. Sanghvi· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Madi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors

M. Kilian, R. Sheinin, C. L. Tan, C. Kraemer, M. Friedrich, A. Kaminitz, K. Sanghvi, K. Lindner, F. Cichon, S. Jung, K. Jaehne, M. Ratliff, R. Prins, A. von Deimling, W. Wick, , M. Platten

This study shows that MHC class II antigen presentation on blood-borne myeloids is essential to maintain functional CD8+ T cells in brain tumors by preventing Tox-driven dysfunction.

Cancer Cell · Feb 1, 2023Peer-reviewedCancer Biology